Affiliations
AffiliationsItem in Clipboard
Perspectives on Oncology-Specific Language During the Coronavirus Disease 2019 Pandemic: A Qualitative StudyLaila A Gharzai et al. JAMA Oncol. 2020.
. 2020 Sep 1;6(9):1424-1428. doi: 10.1001/jamaoncol.2020.2980. AffiliationsItem in Clipboard
AbstractImportance: The novel coronavirus disease 2019 (COVID-19) pandemic has dramatically changed the US health care system, causing an influx of patients who require resources. Many oncologists are having challenging conversations with their patients about how the COVID-19 pandemic is affecting cancer care and may desire evidence-based communication guidance.
Objectives: To identify the clinical scenarios that pose communication challenges, understand patient reactions to these scenarios, and develop a communication guide with sample responses.
Design, setting, and participants: This qualitative study that was conducted at a single Midwestern academic medical center invited physicians to respond to a brief semistructured interview by email or telephone and then disseminated an anonymous online survey among patients with cancer. Oncology-specific, COVID-19-related clinical scenarios were identified by the physicians, and potential reactions to these scenarios were gleaned from the patient responses to the survey. Health communication experts were invited to participate in the iterative development of a communication guide, comprising 3 essential communication principles and strategies and informed by insights from physicians and patients. This study was conducted from March 25, 2020, to April 2, 2020.
Interventions: Expert review, interviews, and surveys assessing challenging situations specific to cancer management during the COVID-19 pandemic.
Main outcomes and measures: Oncology-specific, COVID-19-related clinical scenarios from physician interviews; responses to each scenario from patient surveys; and applicable communication principles from health communication expert literature review.
Results: Of the 8 physicians who participated in interviews, 4 were men (50%) and 4 were women (50%). These physicians represented the following disciplines: internal medicine (n = 1), hematology/oncology (n = 2), radiation oncology (n = 3), and surgical oncology (n = 2). Their disease site specialization included cancers of the breast, head and neck, melanoma, and gastrointestinal and genitourinary tracts. A total of 48 patients with cancer completed the online survey; no demographic information was collected from the patients. The physicians identified 8 oncology-specific, COVID-19-related scenarios in which communication might be challenging: (1) worse outcomes from COVID-19, (2) delay in cancer screening, (3) delay in diagnostic workup, (4) delay in initiation of treatment, (5) offer of nonstandard treatment, (6) treatment breaks, (7) delay in follow-up imaging or care, and (8) inability to be admitted into the hospital for management. Potential patient reactions to each of these scenarios were compiled from survey responses. For most scenarios, patient reactions involved anger, fear, and anxiety (eg, "I'm scared"; "This isn't fair. I am upset."). These emotional patient responses informed the selection of the 3 general communication principles, which suggested language and strategies that physicians can use to respond to patients.
Conclusions and relevance: In this qualitative study, physicians and patients identified communication needs used by health communication experts to inform the development of a practical, evidence-based communication guide for oncology care during the COVID-19 pandemic.
Conflict of interest statementConflict of Interest Disclosures: Dr Jagsi reported receiving grants from the National Institutes of Health, Doris Duke Foundation, Komen Foundation, Blue Cross Blue Shield of Michigan, and Genentech; grants and personal fees from the Greenwall Foundation; personal fees from Amgen, Vizient, Sherinian and Hasso, and Dressman, Benziger, Lavelle outside the submitted work; and stock options for service as an advisor for RJ Equity Quotient. No other disclosures were reported.
Similar articlesHui JYC, Yuan J, Teoh D, Thomaier L, Jewett P, Beckwith H, Parsons H, Lou E, Blaes AH, Vogel RI. Hui JYC, et al. Am J Clin Oncol. 2020 Oct;43(10):679-684. doi: 10.1097/COC.0000000000000757. Am J Clin Oncol. 2020. PMID: 32852291 Free PMC article.
Cinar P, Cox J, Kamal A, Bickel K, Krzyzanowska M, Armitage J, Ganti AK, Ward J, Wong S, Lonial S, Bosserman L. Cinar P, et al. JCO Oncol Pract. 2020 Aug;16(8):431-434. doi: 10.1200/OP.20.00326. Epub 2020 May 28. JCO Oncol Pract. 2020. PMID: 32463764 No abstract available.
DeBoer RJ, Fadelu TA, Shulman LN, Van Loon K. DeBoer RJ, et al. JAMA Oncol. 2020 Sep 1;6(9):1429-1433. doi: 10.1001/jamaoncol.2020.2976. JAMA Oncol. 2020. PMID: 32761149
Dhawan N, Prommer E, Sinclair CT, Subbiah IM. Dhawan N, et al. Curr Treat Options Oncol. 2020 Oct 29;21(12):99. doi: 10.1007/s11864-020-00795-z. Curr Treat Options Oncol. 2020. PMID: 33119833 Free PMC article. Review. No abstract available.
Franco P, Kochbati L, Siano M, De Bari B. Franco P, et al. Biomed Res Int. 2020 May 26;2020:4892382. doi: 10.1155/2020/4892382. eCollection 2020. Biomed Res Int. 2020. PMID: 32509860 Free PMC article. Review.
Sessa C, Cortes J, Conte P, Cardoso F, Choueiri T, Dummer R, Lorusso P, Ottmann O, Ryll B, Mok T, Tempero M, Comis S, Oliva C, Peters S, Tabernero J. Sessa C, et al. ESMO Open. 2022 Feb;7(1):100339. doi: 10.1016/j.esmoop.2021.100339. Epub 2021 Nov 23. ESMO Open. 2022. PMID: 34953404 Free PMC article. Review.
Graetz DE, Sniderman E, Villegas C, Ragab I, Laptsevich A, Maliti B, Naidu G, Zhang H, Gassant P, Nunes L, Arce D, Vasquez JM, Arora RS, Alcasabas AP, Rusmawatiningtyas D, Raza MR, Hamid SA, Velasco P, Kambugu J, Vinitsky A, Bolous NS, Haidar CE, Bihannic L, Sa da Bandeira D, Wang JX, Li D, Graca F, Vasilyeva A, Lesmana H, Galindo CR, Agulnik A, Moreira DC. Graetz DE, et al. Glob Qual Nurs Res. 2022 Feb 26;9:23333936221080969. doi: 10.1177/23333936221080969. eCollection 2022 Jan-Dec. Glob Qual Nurs Res. 2022. PMID: 35237707 Free PMC article.
Freer PE. Freer PE. Radiol Clin North Am. 2021 Jan;59(1):1-11. doi: 10.1016/j.rcl.2020.09.008. Epub 2020 Sep 22. Radiol Clin North Am. 2021. PMID: 33222992 Free PMC article. Review.
Jones JM, Saeed H, Katz MS, Lustberg MB, Forster VJ, Nekhlyudov L. Jones JM, et al. J Natl Cancer Inst. 2021 Aug 2;113(8):955-961. doi: 10.1093/jnci/djaa200. J Natl Cancer Inst. 2021. PMID: 33367655 Free PMC article.
de Las Heras-Pedrosa C, Jambrino-Maldonado C, Rando-Cueto D, Iglesias-Sánchez PP. de Las Heras-Pedrosa C, et al. Int J Environ Res Public Health. 2022 Feb 2;19(3):1705. doi: 10.3390/ijerph19031705. Int J Environ Res Public Health. 2022. PMID: 35162726 Free PMC article. Review.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3